Vincent LoPriore
Vermögen: 3 Mio $ am 30.06.2026
Vermögen: 3 Mio $ am 30.06.2026
Vincent S.
LoPriore is the founder of Gravitas Capital Partners LLC, founded in 2010, where the title held is Managing Partner.
Mr. LoPriore is currently Executive Chairman at Hepion Pharmaceuticals, Inc. since 2026.
Former positions include Chief Executive Officer & Director at Pinkbrick Holdings, Inc. from 2014 to 2015, Director at Canton Strategic Holdings, Inc. in 2026, and Advisor at Bishop Rosen & Co., Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.06.2026 | 944.420 ( 1,22 % ) | 3 Mio $ | 30.06.2026 | |
HEPION PHARMACEUTICALS, INC. 21,46 % | 28.04.2026 | 6.250.000 ( 21,46 % ) | 425 000 $ | 30.06.2026 |
Pinkbrick Holdings, Inc.
Pinkbrick Holdings, Inc. Financial ConglomeratesFinance Operates as a development stage company, which obtains initial financing -.--% | 23.02.2017 | 300.000 ( -.--% ) | - $ | Heute |
| Unternehmen | Position | Beginn |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Vorsitzender | 16.03.2026 |
Gravitas Capital Partners LLC | Gründer | 01.04.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Vorsitzender | 05.02.2026 |
Pinkbrick Holdings, Inc.
Pinkbrick Holdings, Inc. Financial ConglomeratesFinance Operates as a development stage company, which obtains initial financing | Vorstandsvorsitzender | 11.07.2015 |
Bishop Rosen & Co., Inc.
Bishop Rosen & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Bishop Rosen & Co., Inc.
Bishop Rosen & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Pinkbrick Holdings, Inc.
Pinkbrick Holdings, Inc. Financial ConglomeratesFinance Operates as a development stage company, which obtains initial financing | Finance |
Gravitas Capital Partners LLC | |
Tharimmune, Inc.
Tharimmune, Inc. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company that develops novel therapeutic candidates targeting ferroptosis | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen